Wednesday, December 07, 2005


Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain (PDF) (Viral Hepatitis)


Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain (PDF)
... by the Sindbis and Semliki Forest viruses, hepatitis C. virus (HCV) and cytomegalovirus, have been reported. In the life cycle of HCV a crucial role is played by ...

HCV Future Therapies
FUTURE HCV THERAPIES. INTRODUCTION: ... Challenges facing our current treatment of HCV include lack of efficacy in genotype I ... represent a majority of U.S. HCV infections), combination therapy's toxicity, the expense ...

Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy
Back&nbsp. Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy. AIDS 2003; 17(16):2279-2290 ... Coinfection with the hepatitis C virus (HCV) may limit life expectancy because it ... and hepatocellular carcinoma. HCV-induced fibrosis progresses faster in HIV/HCV-coinfected persons ...